The Gross Margin of North China Pharmaceutical Co Ltd (600812.SS) is 31.84%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 31.84% |
| 2023-12-31 | 31.94% |
| 2022-12-31 | 32.79% |
| 2021-12-31 | 35.63% |
| 2020-12-31 | 36.28% |
| 2019-12-31 | 41.31% |
| 2018-12-31 | 41.57% |
| 2017-12-31 | 31.22% |
| 2016-12-31 | 19.07% |
| 2015-12-31 | 17.90% |